Search

Over time, researchers have accumulated significant evidence indicating that vitamin D deficiency not only impacts skeletal health but also contributes to the development and progression of various diseases, including cancer, diabetes, and cardiovascular conditions. The risk of low serum 1, 25(OH)2D3 level ultimately directs the way to morbidity, the beginning of new diseases, and numerous infections. Infections are the first entity that affects those with vitamin D deficiency. The common infection is urinary tract infection (UTI), and its relationship with vitamin D deficiency or insufficiency remains controversial. This infection affects both men and women, but comparatively, women are more prone to this infection because of the short length of the urethra, which makes an easy entry for the bacteria. The low level of serum vitamin D increases the risk of UTIs in children. Recurrent UTIs are one of the major weaknesses in women; if left untreated, they progress to appallingly serious conditions like kidney dysfunction, liver damage, etc. Hence improving the vitamin D status may help to improve the immune system, thus making it more resistant to infections. In this review, we have focused on examining whether vitamin D deficiency and insufficiency are the causes of UTIs and the association between them in women and children. We have also described the connection between vitamin D deficiency and insufficiency with UTIs and additional nanotechnology- based treatment strategies. [ABSTRACT FROM AUTHOR]

In the advancing generation, commercialization and industrial development are on the incessant proliferation. Due to this unremitting need for development, the danger to the biological health of the environment is on the assurgent rise. Many "clean and green" industrial protocols have been generated and taken into purview but has been ineffective in keeping abreast with the ever‐growing pace of environmental threats. Technology in today's world has been the game changer in revolutionizing the way humans live their lives today but at the same time, has also become the greatest source of threat to the very sustainability of the planet. Thus, newer technological enhancements have been initiated to compensate for the harm to the environment. Of these, green and sustainable nanotechnological methodology and tools to be used as zero waste tools have been developed to efficiently beat the crisis of the hour. For example, the development of various nano‐based zero‐waste tools to the introduction of nanotechnology in various industries like automobiles, water, agriculture, and so on, has changed the way sustainable development has been adopted. This article aims to enhance the success of nanotechnology in the various sustainable developments done in industrial fields to cope up with the need of a "clean and green" environment. [ABSTRACT FROM AUTHOR]

Cancer is one of the major causes of death, and its negative impact continues to rise globally. Chemotherapy, which is the most common therapy, has several limitations due to its tremendous side effects. Therefore, developing an alternate therapeutic agent with high biocompatibility is indeed needed. The anti-oxidative effects and bioactivities of several different crude extracts of marine algae have been evaluated both in vitro and in vivo. In the present study, we synthesized the aqueous extract (HA) from the marine algae Amphiroa anceps, and then, a liposome was formulated for that extract (NHA). The extracts were characterized using different photophysical tools like dynamic light scattering, UV–visible spectroscopy, FTIR, scanning electron microscopy, and GC-MS analysis. The SEM image revealed a size range of 112–185 nm for NHA and the GC-MS results showed the presence of octadecanoic acid and n-Hexadecanoic acid in the majority. The anticancer activity was studied using A549 cells, and the NHA inhibited the cancer cells dose-dependently, with the highest killing of 92% at 100 μg/mL. The in vivo studies in the zebrafish model showed that neither the HA nor NHA of Amphiroa anceps showed any teratogenic effect. The outcome of our study showed that NHA can be a potential drug candidate for inhibiting cancer with good biocompatibility up to a dose of 100 μg/mL. [ABSTRACT FROM AUTHOR]